PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) Director Leslie C.G. Campbell purchased 15,000 shares of the business's stock in a transaction that occurred on Wednesday, December 4th. The shares were purchased at an average price of $5.38 per share, for a total transaction of $80,700.00. Following the completion of the acquisition, the director now owns 70,000 shares of the company's stock, valued at $376,600. The trade was a 27.27 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
PetMed Express Price Performance
PETS opened at $5.75 on Friday. The business's fifty day simple moving average is $4.43 and its 200 day simple moving average is $3.98. PetMed Express, Inc. has a 52 week low of $2.90 and a 52 week high of $7.90.
PetMed Express (NASDAQ:PETS - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.17. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. The business had revenue of $59.57 million during the quarter, compared to the consensus estimate of $66.02 million. As a group, analysts expect that PetMed Express, Inc. will post 0.24 EPS for the current fiscal year.
Institutional Trading of PetMed Express
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
From Brownstone Research | Ad
Elon Musk believes his new AI product will be worth an incredible $9 trillion.
But the mainstream media is not buying it.
Click here to watch this demo and decide for yourself.
Several large investors have recently modified their holdings of the business. Point72 DIFC Ltd purchased a new stake in PetMed Express in the second quarter worth $34,000. Price T Rowe Associates Inc. MD increased its position in shares of PetMed Express by 48.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 129,229 shares of the company's stock valued at $620,000 after buying an additional 42,125 shares during the period. Squarepoint Ops LLC bought a new position in PetMed Express in the second quarter worth about $273,000. SG Americas Securities LLC purchased a new stake in PetMed Express in the second quarter worth about $46,000. Finally, Vanguard Group Inc. grew its holdings in shares of PetMed Express by 0.8% during the 1st quarter. Vanguard Group Inc. now owns 1,186,485 shares of the company's stock worth $5,683,000 after acquiring an additional 9,226 shares during the period. 73.33% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Separately, StockNews.com raised shares of PetMed Express from a "hold" rating to a "buy" rating in a report on Tuesday, November 12th.
Get Our Latest Stock Report on PetMed Express
PetMed Express Company Profile
(
Get Free Report)
PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
